Description
Etamzilat (Etamsylate) Tablets 0.25 №50
Composition
Etamzilat (Etamsylate) tablets contain 0.25mg of the active ingredient etamsylate. Other inactive ingredients may include fillers and binders.
Mechanism of Action
Pharmacological Properties: Etamsylate stabilizes blood vessels and increases platelet adhesiveness, promoting improved clot formation. This mechanism aids in effectively controlling bleeding episodes.
Indications for Use
Indications: Etamzilat tablets are indicated for the treatment of various bleeding disorders, such as menorrhagia, epistaxis, and bleeding associated with minor surgical procedures.
Contraindications
Contraindications: Do not use Etamzilat tablets if you are allergic to etamsylate or any other ingredients in the formulation. Consult a healthcare professional before starting this medication.
Side Effects
Side Effects: Etamzilat tablets are generally well-tolerated; however, some individuals may experience mild side effects such as nausea or gastrointestinal discomfort. If severe reactions occur, discontinue use and seek medical advice.
Usage Instructions
Directions: Take Etamzilat tablets as prescribed by your doctor. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
Benefits Compared to Analogues
Etamzilat tablets offer superior efficacy in managing bleeding disorders compared to traditional treatments. The hemostatic effects of etamsylate provide rapid and effective control of bleeding episodes, enhancing patient outcomes.
Suitable Patient Groups
Etamzilat tablets are suitable for use in various patient populations, including adults, children, and the elderly. Dosage adjustments may be necessary based on individual patient characteristics and medical conditions.
Storage and Shelf Life
Storage: Store Etamzilat tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children.
Shelf Life: Check the expiration date on the packaging. Do not use expired tablets.
Packaging Description
The packaging of Etamzilat tablets contains 50 tablets of 0.25mg strength. Each blister pack is labeled with essential information, including the name of the product, dosage, and expiry date.
Clinical Evidence and Proven Effectiveness
Clinical Studies: Etamsylate, the active ingredient in Etamzilat tablets, has been extensively researched for its hemostatic properties. Studies have demonstrated the efficacy of etamsylate in various bleeding disorders, supporting its use in clinical practice.
Research Findings: Clinical trials have shown that etamsylate effectively reduces bleeding episodes and improves hemostatic parameters in patients with bleeding disorders, validating its therapeutic benefits.
